Patient Experience and Improvement Opportunities in Self-Administered, Large-Volume Subcutaneous Infusions at Home
Although patients prefer LVSC administration at home compared to the alternatives, the current SCIg use process presents a variety of challenges. While not all of these factors will apply to every LVSC scenario, these insights, along with their corresponding implications for device design, provide a framework to inform user needs for LVSC self-administration, anticipate obstacles during development of new LVSC therapies, and improve existing delivery devices.
Authors
- James Hawthorne (ORCID: https://orcid.org/0000-0003-1963-9253)
- Dimos Katsaros (ORCID: https://orcid.org/0000-0001-8600-2696)
- Christopher Franzese (ORCID: https://orcid.org/0000-0003-3861-0691)
- Marty Coyne (ORCID: https://orcid.org/0000-0001-8006-1927)
Institutions
- University of Rhode Island (US)
- TE Laboratories (Ireland) (IE)
- Synta Pharmaceuticals (United States) (US)
- Rhode Island College (US)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/ppa.s515565
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00